BIG NEWS! MBF Bioscience is excited to announce a leadership transition. Effective October 1, 2026, Veronica Pessino, PhD, was appointed CEO of MBF Bioscience. Founder Jack Glaser will continue to serve the company through efforts from the Board.
Veronica joined MBF in 2025 and has served as President since January 2026. She brings a background in neuroscience research and experience leading scientific technology businesses. She will lead MBF's next chapter, with a continued focus on serving researchers through our imaging and analysis software and hardware.
Jack co-founded MBF in 1988 and under his leadership, tools like Neurolucida and Stereo Investigator became standards in quantitative neuroscience.
Thank you, Jack, and congratulations, Veronica.